Search Results - "Gabbuti, Andrea"

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents by Gabbuti, Andrea, Romanò, Luisa, Blanc, Pierluigi, Meacci, Francesca, Amendola, Antonella, Mele, Alfonso, Mazzotta, Francesco, Zanetti, Alessandro R

“…Abstract In 1992, 620 adolescents were vaccinated against hepatitis B. Anti-HBs concentrations were measured in 480 (77.4%) adolescents 1 month after…”
Get full text

Nosocomial Bloodstream Infections among Human Immunodeficiency Virus–Infected Patients: Incidence and Risk Factors by Petrosillo, Nicola, Viale, Pierluigi, Nicastri, Emanuele, Arici, Claudio, Bombana, Enrico, Casella, Alberto, Cristini, Francesco, De Gennaro, Michele, Dodi, Ferdinando, Gabbuti, Andrea, Gattuso, Gianni, Irato, Laura, Maggi, Paolo, Pallavicini, Federico, Pan, Angelo, Pantaleoni, Mario, Ippolito, Giuseppe

“…To assess the incidence of nosocomial bloodstream infections (NBSIs) in human immunodeficiency virus (HIV)—infected patients, and to analyze the main…”
Get full text

Potential remdesivir‐related transient bradycardia in patients with coronavirus disease 2019 (COVID‐19) by Pallotto, Carlo, Suardi, Lorenzo R., Gabbuti, Andrea, Esperti, Sara, Mecocci, Lorenzo, Blanc, Pierluigi

Get full text

Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study by Stasi, Cristina, Monnini, Mirko, Cellesi, Valerio, Salvadori, Marco, Marri, Daniele, Ameglio, Mateo, Gabbuti, Andrea, Di Fiandra, Teresa, Voller, Fabio, Silvestri, Caterina

“…Vaccine against hepatitis B virus (HBV) is highly effective in preventing HBV infection. The aims of this study were to (1) increase the epidemiological…”
Get full text

Remdesivir treatment and transient bradycardia in patients with coronavirus diseases 2019 (COVID-19) by Pallotto, Carlo, Blanc, Pierluigi, Esperti, Sara, Suardi, Lorenzo Roberto, Gabbuti, Andrea, Vichi, Francesca, Mecocci, Lorenzo, Esposti, Anna Degli, Pierotti, Piera, Attala, Letizia, Salomoni, Elena, Baragli, Filippo, Francisci, Daniela, Pietro, Massimo Antonio Di

“…•Remdesivir is the only antiviral approved for COVID-19.•Remdesivir treatment was associated with transient bradycardia.•Bradycardia did not cause any severe…”
Get full text

Ways to promote screening for hepatitis B virus and accelerated vaccination schedule in prison: Training, information, peer education by Stasi, Cristina, Monnini, Mirko, Cellesi, Valerio, Salvadori, Marco, Marri, Daniele, Ameglio, Mateo, Gabbuti, Andrea, Celmi, Rossella, Di Fiandra, Teresa, Voller, Fabio, Silvestri, Caterina

“…The World Health Organization has suggested prioritizing preventive measures for communicable diseases, including the hepatitis B virus (HBV) infection. To…”
Get more information

Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study by Bonfanti, Paolo, Valsecchi, Laura, Parazzini, Fabio, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Timillero, Lia, Alessi, Federica, Ghiselli, Giancarlo, Gabbuti, Andrea, Di Cintio, Elisabetta, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana

Get full text

Efficacy of highly active antiretroviral therapy in HIV-infected, institutionalized orphaned children in Tanzania by Blè, Claudio, Floridia, Marco, Muhale, Celine, Motto, Stephen, Giuliano, Marina, Gabbuti, Andrea, Giuman, Lucia, Mazzotta, Francesco

Get full text

Incidence of adverse reactions in HIV patients treated with protease inhibitors : A Cohort Study by BONFANTI, P, VALSECCHI, L, DI CINTIO, E, MARTINELLI, C, FAGGION, I, LANDONIO, S, QUIRINO, T, PARAZZINI, F, CARRADORI, S, PUSTERLA, L, FORTUNA, P, TIMILLERO, L, ALESSI, F, GHISELLI, G, GABBUTI, A

“…To assess the probability that protease inhibitor (PI) therapy might be discontinued because of adverse events (AE) and to evaluate the incidence rate of…”
Get full text

Chlamydia Pneumoniae Seropositivity and Cardiovascular Risk Factors: The InCHIANTI Study by Blanc, Pierluigi, Corsi, Anna Maria, Gabbuti, Andrea, Peduzzi, Cecilia, Meacci, Francesca, Olivieri, Fabiola, Lauretani, Fulvio, Francesco, Mazzotta, Ferrucci, Luigi

“…Objectives: To assess the prevalence of Chlamydia pneumoniae (CP) seropositivity and test the hypothesis that CP infection (CPI) is associated with…”
Get full text

Risk factors for lipodystrophy in the CISAI cohort by Bonfanti, Paolo, Gulisano, Cecilia, Ricci, Elena, Timillero, Lia, Valsecchi, Laura, Carradori, Silvia, Pusterla, Luigi, Fortuna, Paolo, Miccolis, Sebastiano, Magnani, Carlo, Gabbuti, Andrea, Parazzini, Fabio, Martinelli, Canio, Faggion, Ivano, Landonio, Simona, Quirino, Tiziana, Vigevani, GianMarco

“…Purpose. – This study set out to describe the frequency of lipodystrophy, and identify its risk factors, in HIV-positive patients treated with HAART containing…”
Get full text

HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients by Quirino, T, Niero, F, Ricci, E, Pusterla, L, Carradori, S, Gabbuti, A, Iemoli, E, Landonio, S, Faggion, I, Bonfanti, P

“…The aim of our study is to compare the tolerability of zidovudine/lamivudine/indinavir when used in post-exposure prophylaxis (PEP) subjects and in…”
Get full text

Oseonecrosis in protease inhibitor-treated patients by Bonfanti, Paolo, Gabbuti, Andrea, Carradori, Silvia, Pusterla, Luigi, Parazzini, Fabio, Lindonio, Simona, Quirino, Tiziana

“…The introduction of protease inhibitors has proven a watershed in human immunodeficiency virus infection therapy and has initiated an era of highly active…”
Get full text

Osteonecrosis in protease inhibitor-treated patients. Discussion by BONFANTI, Paolo, GABBUTI, Andrea, CARRADORI, Silvia, PUSTERLA, Luigi, PARAZZINI, Fabio, LANDONIO, Simona, QUIRINO, Tiziana

Get full text

Osteonecrosis in protease inhibitor-treated patients by Bonfanti, P, Grabbuti, A, Carradori, S, Pusterla, L, Parrazini, F, Landonio, S, Quirino, T

“…The introduction of protease inhibitors has proven a watershed in human immunodeficiency virus infection therapy and has initiated an era of highly active…”
Get full text